NSD-644

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNSD-644
Drug Alias NameNSD-644
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsAdrenergic receptors antagonistsDopamine reuptake inhibitors
TargetsDopamine transporterAdrenergic receptorsSerotonin transporter
Therapy Area/IndicationsNeuralgiaCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcNeurosearch As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch AsGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsNeuralgiaCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A